Skip to main content
TipRanks
Go Ultimate75% OFF

Med Biogene (MBI.H) Financial Statements

4 Followers

Med Biogene Financial Overview

Med Biogene's market cap is currently $258.87K. The company's EPS TTM is ―; its P/E ratio is -4.05; Med Biogene has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue―――――
Gross Profit―――――
Operating Income$ -58.11K$ -63.06K$ -59.96K$ -54.54K$ -63.48K
EBITDA$ -58.11K$ -63.06K$ -59.96K$ -54.54K$ -63.48K
Net Income$ -58.11K$ -63.06K$ -59.96K$ -54.54K$ -63.48K
Balance Sheet
Cash & Short-Term Investments―――――
Total Assets$ 2.31K$ 3.00K$ 10.79K$ 81.83K$ 13.15K
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -713.00$ -407.00$ -9.19K$ -79.24K$ -10.96K
Total Liabilities$ 129.30K$ 69.23K$ 92.01K$ 178.16K$ 50.42K
Stockholders' Equity―――――
Cash Flow
Free Cash Flow―$ -8.32K$ -145.12K$ 72.80K$ -151.46K
Operating Cash Flow―――――
Investing Cash Flow―――――
Financing Cash Flow―――――

Currency in USD

Med Biogene Earnings and Revenue History

-60K-40K-20K00 %0.4 %0.8 %1.2 %EarningsProfit Margin2020RevenueEarningsProfit Margin

Med Biogene Liabilities to Assets

080K160K240K216 %217 %218 %219 %LiabilitiesLiabilities to Assets2020AssetsLiabilitiesLiabilities to Assets

Med Biogene Cash Flow

00.30.50.811.32020OperatingInvestingFinancing

Med Biogene Forecast EPS vs Actual EPS

0000000Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss